Related Experiment Videos
Current therapies for glioblastoma
1Department of Neuro-Oncology, University of Texas M. D. Anderson Cancer Center, TX, USA.
Clinical Advances in Hematology & Oncology : H&O
|September 16, 2005
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Tumor-initiating genetics and therapy drive divergent molecular evolution in IDH-mutant gliomas.
bioRxiv : the preprint server for biology·2025
Oncogenic drivers shape the tumor microenvironment in human gliomas.
bioRxiv : the preprint server for biology·2025
The multilayered transcriptional architecture of glioblastoma ecosystems.
Nature genetics·2025
Clinical applications of PARP inhibitors in breast, ovarian, and prostate cancer: current insights and future directions.
Clinical advances in hematology & oncology : H&O·2026
Molecular residual disease (MRD) testing: advancing clinical decision-making in breast cancer.
Clinical advances in hematology & oncology : H&O·2026
Hemophagocytic lymphohistiocytosis: new grading classification and targeted therapies.
Clinical advances in hematology & oncology : H&O·2026
A Novel tsRNA, 5'tiRNA-GluCTC, Mediates Cardiomyocyte-Fibroblast Crosstalk to Promote Cardiac Fibrosis in Restrictive Cardiomyopathy.
Clinical science (London, England : 1979)·2026
A Metabo-Reprogramming Niche Remodeling System Halts Osteoarthritis by Restoring the FGF21-Arginine Axis.
Advanced materials (Deerfield Beach, Fla.)·2026
Spatiotemporally Controlled Lysosomal Membrane Permeabilization Amplifies STING-Driven Antitumor Immunity in Prostate Cancer.
Advanced materials (Deerfield Beach, Fla.)·2026
Programmed Cell Death: A Key Mechanism of Traditional Chinese Medicine in the Treatment of Membranous Nephropathy.
Drug design, development and therapy·2026